30, 1976. lengthened in the nonischemic as well as in the ischemic areas, but the changes were such that the temporal dispersion caused by the coronary ligation was reduced from 12.2% to 5.5% (P < 0.01) after 10 minutes, and to 5.0% (P < 0.02) after 20 minutes of drug infusion. It is concluded that procainamide exerts different overall effects on the nonischemic and acutely ischemic canine myocardium. It is postulated that this action may play a role in the suppression of re-entrant arrhythmias.
MethodsFourteen mongrel dogs weighing 17 to 26 kg were anesthetized with intravenous sodium pentobarbital, 30 mg/kg, intubated and mechanically respirated with a Harvard respirator. The left femoral vein was catheterized for administration of drugs and to obtain blood samples for determination of procainamide levels, and the aortic pressure monitored via a catheter introduced in the left femoral artery, using a Statham P23Db transducer. After induction of complete heart block by injecting 0.2 ml of formaldehyde in the septum in the area of the bundle of His, heart rate was kept constant at a basic cycle length (SI -SI) of 500 msec by right ventricular pacing using a S-88 Grass stimulator. Four pairs of fine stainless-steel, Teflon-coated plunge electrodes (0.003 inch diameter) were inserted into the left ventricular myocardium, two pairs in an area subserved by the left anterior descending coronary artery that subsequently was made ischemic and the other two pairs in an area with intact coronary blood flow. Premature stimuli (S2) were introduced in each left ventricular zone through a pair of stimulating electrodes and a pair of sensing electrodes was placed at a distance of 5-8 mm.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.